Landscape Capital Management L.L.C. Increases Stock Position in CVS Health Co. (NYSE:CVS)

Landscape Capital Management L.L.C. lifted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 55.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 117,729 shares of the pharmacy operator's stock after acquiring an additional 42,205 shares during the period. CVS Health makes up 0.6% of Landscape Capital Management L.L.C.'s portfolio, making the stock its 20th biggest position. Landscape Capital Management L.L.C.'s holdings in CVS Health were worth $5,285,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Ridgewood Investments LLC grew its holdings in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 450 shares during the period. Stonebridge Financial Group LLC acquired a new position in CVS Health in the fourth quarter worth approximately $28,000. Hopwood Financial Services Inc. bought a new position in shares of CVS Health in the 4th quarter valued at approximately $29,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the 3rd quarter worth $31,000. Finally, Financial Perspectives Inc boosted its holdings in CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after acquiring an additional 466 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analyst Weigh In

CVS has been the topic of a number of research reports. Evercore ISI boosted their price objective on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday, January 27th. JPMorgan Chase & Co. increased their target price on CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a report on Tuesday, February 18th. Wolfe Research lifted their target price on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Finally, Truist Financial increased their target price on CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $70.39.

Remove Ads

Insider Activity at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction on Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of the company's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by insiders.

CVS Health Stock Down 5.9 %

Shares of NYSE:CVS traded down $3.97 on Friday, reaching $63.54. The company had a trading volume of 13,291,234 shares, compared to its average volume of 11,586,970. The firm has a market capitalization of $80.11 billion, a PE ratio of 17.36, a PEG ratio of 0.98 and a beta of 0.57. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $74.85. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm's 50 day simple moving average is $63.47 and its 200-day simple moving average is $58.01.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.19%. CVS Health's dividend payout ratio is presently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.